Search

everythinglearnresearchcommunity

for

Search:↓

PRP injections did not significantly improve ovarian function in women with low ovarian reserve.

Six months of treatment improved PCOS symptoms and reduced AMH levels.

Proxalutamide significantly lowered hospitalization rates in women with mild-to-moderate COVID-19.

Cyproterone acetate combined with ethinyl estradiol significantly reduced hirsutism in women.

Resveratrol improved menstrual regularity and reduced hair loss in women with PCOS.

Cyproterone acetate with ethynyl estradiol significantly improved acne and seborrhea in women, but was less effective for hair loss and excessive hair growth.

Flutamide combined with a low-dose birth control pill effectively reduces excessive hair growth in women with polycystic ovarian disease.

Oral spironolactone effectively promotes hair growth in premenopausal women but may cause irregular menstruation.

Proxalutamide improved blood markers related to inflammation, immune response, and clotting in COVID-19 patients, potentially reducing hospitalizations.

Both Diane 35 combinations effectively and safely reduce hirsutism and acne, with potential for better results if treatment extends beyond 12 months.

Oral contraceptives can affect skin and hair, improve acne, but may cause pigmentation, dermatitis, and other conditions.

Neurosteroids affect prolactin levels in sheep differently depending on stress and pregnancy conditions.

Oral contraceptives with desogestrel and drospirenone improve PCOS symptoms.

Progesterone reduces anxiety without needing progesterone receptors.

Diane® is an effective contraceptive that also helps treat acne and mild hair growth issues.

Long-term use of finasteride in women can cause hormonal changes, DNA damage, and menstrual issues.

Adequate steroid treatment needed to limit bone loss in PMR patients.

Some hormone treatments might raise breast cancer risk, while others don't seem to.

Hormonal contraceptives and related compounds can increase health risks like thrombosis and affect sexual function.

Birth control pills slightly increase the risk of breast cancer, especially if used before the first full-term pregnancy.

The oral contraceptive alone is the preferred treatment for hirsutism, as adding the GnRH analog showed no significant benefit.

Low-dose finasteride can cause painful breast enlargement in men, which resolves after stopping the medication.

Cyproterone acetate is the preferred treatment for women's hyperandrogenism when estrogen/progestogen use is safe.

Finasteride effectively reduces excess hair in women with certain conditions.